Dyadic International expands license agreement With Abengoa
Green Car Congress
MAY 2, 2012
a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, biochemical, biopharmaceutical and industrial enzyme industries, $5.5 million for an expansion of its rights under the non-exclusive license agreement the parties entered into in February 2009.
Let's personalize your content